These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3074294)

  • 1. Clinical experience with NovoPen II and insulin Protaphane HM Penfill.
    Kølendorf K; Beck-Nielsen H; Oxenbøll B
    Postgrad Med J; 1988; 64 Suppl 3():14-6; discussion 21. PubMed ID: 3074294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixtard 30 HM Penfill insulin treatment in selected young insulin-dependent diabetes mellitus patients. Romanian Young Diabetics Study Team (RYDST).
    Rom J Intern Med; 1997; 35(1-4):99-113. PubMed ID: 9562659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of insulin loss in treatment of diabetics using the classical syringe or the insulin pen (Novopen II)].
    Krahulec B; Strbová L; Seböková E; Cárský J; Klimes I
    Vnitr Lek; 1996 Sep; 42(9):640-5. PubMed ID: 8984774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient acceptability of a new 3.0 ml pre-filled insulin pen.
    D'Eliseo P; Blaauw J; Milicević Z; Wyatt J; Ignaut DA; Malone JK
    Curr Med Res Opin; 2000; 16(2):125-33. PubMed ID: 10893656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.
    Sucic M; Galic E; Cabrijan T; Ivandic A; Petrusic A; Wyatt J; Mincheva N; Milicevic Z; Malone J
    Med Sci Monit; 2002 Mar; 8(3):PI21-6. PubMed ID: 11884952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of conventional twice daily subcutaneous insulin administration and a multiple injection regimen (using the NovoPen) in insulin-dependent diabetes mellitus.
    Small M; MacRury S; Boal A; Paterson KR; MacCuish AC
    Diabetes Res; 1988 Jun; 8(2):85-9. PubMed ID: 3067951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents.
    Kadiri A; Chraibi A; Marouan F; Ababou MR; el Guermai N; Wadjinny A; Kerfati A; Douiri M; Bensouda JD; Belkhadir J; Arvanitis Y
    Diabetes Res Clin Pract; 1998 Jul; 41(1):15-23. PubMed ID: 9768368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of unstable diabetes mellitus in children and adolescents using insulin administered by a semi-automated syringe, NovoPen].
    Necić S; Nikezić M; Sajić S; Radmanović S
    Srp Arh Celok Lek; 1989; 117(7-8):453-8. PubMed ID: 2688138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability and safety of a new 3.0 ml re-usable insulin pen (HumaPen) in clinical use.
    Martin JM; Llewelyn JA; Ristic S; Bates PC
    Diabetes Nutr Metab; 1999 Oct; 12(5):306-9. PubMed ID: 10741343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic control and acceptance of a regimen of multiple injections using an insulin (novopen) injector in a group of juvenile diabetics].
    Ugart Líbano R; Ruiz de Larrea Pérez C; Edroso Albaina L
    An Esp Pediatr; 1990 Apr; 32(4):299-302. PubMed ID: 2368991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin therapy using a new injection device. Experience with 36 type I diabetics].
    Stracke H; Federlin K
    Dtsch Med Wochenschr; 1987 Mar; 112(10):385-8. PubMed ID: 3545743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A pen-injector of insulin in young diabetics: freedom and excessive weight gain].
    Dorchy H
    Pediatrie; 1988; 43(8):697-702. PubMed ID: 3065723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.
    Stockl K; Ory C; Vanderplas A; Nicklasson L; Lyness W; Cobden D; Chang E
    Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [NovoPen. An aid in multi-injection insulin therapy].
    Paus PN; Jervell J; Berg TJ; Frosta T; Larsen S
    Tidsskr Nor Laegeforen; 1986 Aug; 106(24):1943-6. PubMed ID: 3535163
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient acceptance and issues of education of two durable insulin pen devices.
    Asakura T; Seino H; Jensen KH
    Diabetes Technol Ther; 2008 Aug; 10(4):299-304. PubMed ID: 18715204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen.
    Saurbrey N; Arnold-Larsen S; Møller-Jensen B; Kühl C
    Diabet Med; 1988 Mar; 5(2):150-3. PubMed ID: 2964981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. InDuo, a novel combined insulin injection and blood glucose monitoring device - effective and save as other devices, and patient preference.
    Haupt A; Berg B; Paschen P; Dreyer M; Häring HU; Smedegaard J; Skovlund SE; Matthaei S
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):541-4. PubMed ID: 16235158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of preference for NovoPen(®) 4 with previous insulin pen treatments after 12 weeks in adult patients with type 1 and type 2 diabetes: a multicenter observational study.
    Israël-Bultman H; Hyllested-Winge J; Kolaczynski M; Steindorf J; Garon J
    Clin Ther; 2011 Mar; 33(3):346-57. PubMed ID: 21600387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pen injector for insulin-requiring diabetic patients.
    Hung CT; Wang FF
    J Formos Med Assoc; 1992 Oct; 91(10):1026-9. PubMed ID: 1362671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical response and patient acceptance of a prefilled, disposable insulin pen injector for insulin-treated diabetes.
    Chen HS; Hwu CM; Kwok CF; Yang HJ; Shih KC; Lin BJ; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):455-60. PubMed ID: 10418181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.